Please login to the form below

Not currently logged in
Email:
Password:

nonacog beta pegol

This page shows the latest nonacog beta pegol news and features for those working in and with pharma, biotech and healthcare.

Novo Nordisk wins European approval for Refixia

Novo Nordisk wins European approval for Refixia

The half-life of Refixia (nonacog beta pegol or N9-GP) is around five times longer.

Latest news

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics